


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+14.75%
-1.49%
-1.11%
+13.74%
+2.71%
LH
Laboratory Corporati
$284.50
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market
LH Price Performance
$261.99 (+8.59%)
$266.83 (+6.62%)
$278.9 (+2.01%)
$257.2 (+10.61%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
LH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LH Street Sentiment is extremely bullish and have positive views on the near-term outlook
LH has Fair risk level
Risks Indicators

Beta greater than 1.0

Investors losing confidence

EXAS
Exact Sciences
103.35
+0.03%
DGX
Quest Diagnostics
205.35
+7.37%
HUM
Humana
181.30
-4.32%
GH
Guardant Health
105.03
-0.29%
What is LH current stock price?
What are LH stock strengths?
What is LH Risk Level?
What is LH market cap and volume?
What is LH current Stock IQ?
Should I buy LH stock right now?
Is LH a Strong Buy right now?
What does a 'Strong Buy' rating mean for LH?
What does a 'Strong Sell' rating mean for LH?
What factors influence LH's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+14.75%
-1.49%
-1.11%
+13.74%
+2.71%
LH
Laboratory Corporati
Current Price
$284.50
Runners Also Watch
EXAS
Exact Sciences
103.35
+0.03%
DGX
Quest Diagnostics
205.35
+7.37%
HUM
Humana
181.30
-4.32%
GH
Guardant Health
105.03
-0.29%

LH Price Performance
$261.99 (+8.59%)
$266.83 (+6.62%)
$278.9 (+2.01%)
$257.2 (+10.61%)
LH Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
LH Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
LH Street Sentiment is extremely bullish and have positive views on the near-term outlook
LH has Fair risk level
Risks Indicators

Beta greater than 1.0

Investors losing confidence

LH Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market
LH Latest Analysis
BD shares fall by 3% after lowering FY26 profit outlook. Becton Dickinson and Company (BD) has trimmed its fiscal year 2026 (FY26) profit outlook to account for the spin-off of its biosciences &. diagnostic solutions business prompting its share price to fall by 3%.BD reached a $17.5bn agreement to merge the unit with Waters a laboratory equipment
Today
Parsons Awarded $125M Contract to Support the United States Army Combat Capabilities Development Command Army Research Laboratory. CHANTILLY Va. Feb. 10 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:) has been awarded a $125 million single-award Task Order contract over five years to support the United States Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL) High Performance Computing Modernization Program (HPCMP) and Defense Research and Engineering Netwo
Today
United States Space Force Taps Workera to Build the Nations AI-Ready Space Workforce. Partnership will deliver mission-critical skills data for more than 14000 Guardians accelerating mastery of AI cybersecurity and other priority capabilities. the leading AI-powered skills intelligence platform announces it has been selected by SpaceWERX for a Tactical Funding Increase (TACFI) focused on precise future-ready skill verification and development to address the most pressing challenges in the Depart
Wed Feb 4, 2026
Antlara Dental introduces its in-house laboratory. ANTALYA Turkey Jan. 23 2026 /PRNewswire/ -- Antlara Dental has launched an advanced in-house laboratory service. This new service helps make and fit dental restorations more smoothly. It brings together modern digital design and production with expert hand finishing all inside the...
Fri Jan 23, 2026
Argenta Silver Corp. Intersects 246 g/t Ag over 20.00m and Discovers New Gold-Copper Target at El Quevar Project and Adoption of RSU/PSU/DSU Plan. Argenta Silver Corp. (TSXV:) (OTCQX:) (FSE: T1K) (".Argenta". or the ".Company".) is pleased to announce the initial assay results from its 2025–2026 Summer Diamond Drilling Campaign at the El Quevar Project in high-grade silver intervals within the Yaxtché Deposit highlighted by 246 g/t Ag over 20.00 meters including 427 g/t Ag over 6.00
Wed Jan 21, 2026
Gillson Sciences Partners with SanAir Technologies Expanding Environmental Testing Capabilities and Advancing a Holistic Approach to Human Health. CHICAGO Jan. 21 2026 /PRNewswire/ -- Gillson Sciences a leader in analytical laboratory testing and scientific solutions announced their partnership with SanAir Technologies Laboratory Inc. (SanAir) an accredited and diversified environmental testing laboratory specializing in...
Wed Jan 21, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.